Universidad Peruana Cayetano Heredia
Teplizumab approval for type 1 diabetes in the USA.
JavaScript is disabled for your browser. Some features of this site may not work without it.
Mostrar el registro sencillo del ítem
| dc.contributor.author | Beran, David | |
| dc.contributor.author | Abidha, Carol | |
| dc.contributor.author | Adler, Amanda | |
| dc.contributor.author | de Beaufort, Carine | |
| dc.contributor.author | Lepeska, Molly | |
| dc.contributor.author | Levitt, Naomi | |
| dc.contributor.author | Pfiester, Elizabeth | |
| dc.contributor.author | Zafra Tanaka, Jessica Hanae | |
| dc.contributor.author | Gale, Edwin Am | |
| dc.date.accessioned | 2023-02-20T13:28:11Z | |
| dc.date.available | 2023-02-20T13:28:11Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12866/13159 | |
| dc.description.abstract | The US Food and Drug Administration's (FDA) approval of teplizumab to delay the onset of type 1 diabetes could be seen as symbolic, because it came a century after the first use of insulin. Teplizumab, an anti-CD3 monoclonal antibody, is now approved in the USA for people at high risk of type 1 diabetes. This approval is a highly welcome development for this population and all those involved in the care and wellbeing of people with type 1 diabetes. However, in our opinion, the approval of teplizumab should be interpreted with caution. A global health perspective must consider evidence, cost, patient preferences, and equity... | en_US |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.ispartofseries | Lancet. Diabetes and Endocrinology | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
| dc.subject | Teplizumab | en_US |
| dc.subject | type 1 diabetes | en_US |
| dc.subject | USA | en_US |
| dc.subject.mesh | Diabetes Mellitus, Type 1 | |
| dc.subject.mesh | United States | |
| dc.title | Teplizumab approval for type 1 diabetes in the USA. | en_US |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.doi | https://doi.org/10.1016/S2213-8587(22)00384-9 | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.18 | |
| dc.relation.issn | 2213-8595 |
Ficheros en el ítem
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos en revistas indizadas [4988]
Recuperados de bases de datos bibliográficas
Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess
